What’s Happening with Medicaid Work Requirements?
On October 29, a federal court in Boston provided a win to the patient community when it ruled that CMS’s definition of medical frailty is unlawful. As a reminder, in CMS’s June 1 guidance on implementation of the Medicaid work requirements, the agency said that in addition to meeting one of the medical frailty categories outlined in HR 1, including having a serious or complex medical condition, an individual’s condition must also significantly impair the individual’s ability to comply with the community engagement requirement. A June 30 lawsuit, brought by 25 States and the District of Columbia, argued that this additional requirement defied Congress’ intent to protect medically frail individuals from coverage loss and burdensome paperwork. In September, NBDF along with 70 other patient advocacy and civil rights groups filed an amicus brief in support of this lawsuit.
Legal experts are still determining the full implications of the recent ruling, and most anticipate that the Trump Administration will appeal it. The language of the ruling strikes down portions of the June 1 IFR which require “significant impairment” of an individual’s ability to work on a nationwide basis. Nothing in the ruling delays the January 1, 2027, overall launch date for Medicaid work requirements, though advocates have cited the ruling as reason for CMS to reverse its stance and grant states “good faith effort” waivers to allow sufficient time to implement their legally mandated work requirement programs.
CMS Releases Rule Changing Eligibility Requirements for ACA Plans
On October 23, CMS released a proposed rule implementing new requirements under HR 1 related to eligibility and verification for individuals on ACA exchange plans. Among other changes, the rule would end the current policy to provide financial assistance to enrollees during the “inconsistency period” after enrollment and before income has been fully verified. It would implement a new pre-open enrollment verification period starting on August 1st each year in which consumers can choose to submit verification info early. More details can be found in the CMS factsheet.
NBDF and Partner Organizations Submit Comments to USP
NBDF, alongside the Hemophilia Alliance, the Hemophilia Federation of America, and the Coalition for Hemophilia B, submitted comments on the Draft of the United States Pharmacopeia (USP) Drug Classification for 2027. USP drug classifications are important because they are the basis for creating health plan drug formularies – and for evaluating the adequacy of those formularies. NBDF and allied groups have previously asked USP to revise its classification to appropriately differentiate among blood products based on what conditions and populations they treat, mechanisms of action, and routes of administration (currently, USP combines all bleeding disorders medications into a single category and class). While USP has acknowledged the differences among the products, the organization has declined to make the revisions requested. In this year’s comments, NBDF and co-signers reiterated our request and cautioned that combining all bleeding disorders products into a single category and class harms bleeding disorders patients by allowing for the adoption of unduly narrow formularies.
NBDF Responds to US Senate Finance Committee Request for Information on Health Insurance Coverage
On October 2, NBDF submitted comments in response to the Senate Finance Committee’s Request for Information (RFI), Health Coverage that Works for Everyone. The RFI is part of a series of requests that have been issued by the Senate Finance Committee – the Democrats will use these RFIs to help set a policy agenda should they take back control of the Senate. NBDF’s response to the RFI highlighted the many issues faced by the bleeding disorders community in regard to health insurance coverage. It highlighted the high cost of bleeding disorders treatments and the lack of cheaper alternatives; the harms caused by copay diversion tactics, such as copay accumulator adjusters and copay maximizers; the need to improve access to health insurance, to simplify eligibility and enrollment processes, and to restore enhanced advance premium tax credits; the importance of robust network adequacy standards (to ensure individuals living with bleeding disorders have access to an HTC); and much more.
NBDF Insurance Toolkit - Out Now!
Choosing a health insurance plan that fits your needs is one of the most important things you can do if you have a bleeding disorder. Whether you are choosing a plan through your employer, a marketplace plan, or a managed care plan, you need to carefully consider what the plan offers, including how much you will pay, the size of the network, and prescription coverage.
NBDF's Health Insurance Toolkit will help you with the process. It contains worksheets to help you figure out costs, a glossary of terms, helpful fact sheets, and links to available resources.